SEC Form 4 · accession 0001171843-26-004216
Brainsway Ltd. · BWAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gilad Moiseyev
Officer — Chief Technology Officer
Period of report
May 25, 2026
Accepted (ET)
Jun 22, 2026 · 4:04 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001505065
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | May 25, 2026 | M | 7,500 | — | A | 60,000 | D | |
| Ordinary SharesF1,F4,F3 | May 25, 2026 | F | 1,902 | — | D | 58,098 | D | |
| Ordinary SharesF1,F5,F3 | Jun 15, 2026 | S$0 | 5,000 | — | D | 53,098 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2,F6,F1 | — | May 25, 2026 | M | 7,500 | D | — | Mar 5, 2034 | Ordinary Shares | 7,500 | 22,500 | D |
Explanation of responses
- F1The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- F2The exercise price is NIS 11.17 per share.
- F3This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.
- F4These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person.
- F5The sale price was NIS 42.0397 per share.
- F6Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028.